Objective
To determine whether cystic fibrosis (CF) is associated with adverse neonatal outcomes in a recent birth cohort in the United States.
Study design
A retrospective matched cohort study of infants born in Washington State from 1996-2013 was identified through birth certificate data and linked to statewide hospital discharge data. Infants with CF were identified by hospitalization (through age 5 years) in which a CF-specific ICD-9 code was recorded. “Unexposed” infants lacked CF-related ICD-9 codes and were randomly selected among births, frequency-matched to “exposed” infants on birth year. Associations of CF with adverse neonatal outcomes (low birth weight, small for gestational age, pre-term birth and infant mortality) were estimated through Poisson regression. We performed extreme value imputation to address possible ascertainment bias.
Results
We identified 170 infants with CF and 3,400 unexposed infants. CF was associated with increased relative risk (95% confidence interval) of 3.5 (2.5-4.9), 1.6 (1.1-2.4), 3.0 (2.2-4.0), and 6.8 (1.7-26.5) for low birth weight, small for gestational age, pre-term birth, and infant death, respectively. The estimated relative risks were similar among infants born from 2006-2013, except small for gestational age was no longer associated with CF diagnosis. Results were robust to extreme value imputation and exclusion of infants with meconium ileus.
Conclusions
Observed associations of CF with low birth weight, pre-term birth and infant death are unlikely to be due to ascertainment bias. Further work is needed to determine how to prevent these adverse neonatal outcomes.